Morphine Side Effects in β-Arrestin 2 Knockout Mice
Top Cited Papers
- 1 September 2005
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 314 (3) , 1195-1201
- https://doi.org/10.1124/jpet.105.087254
Abstract
Morphine is a potent analgesic, yet, like most opioid narcotics, it exerts unwanted side effects such as constipation and respiratory suppression, thereby limiting its clinical utility. Pharmacological approaches taken to preserve the analgesic properties, while eliminating the unwanted side effects, have met with very limited success. Here, we provide evidence that altering μ opioid receptor regulation may provide a novel approach to discriminate morphine's beneficial and deleterious effects in vivo. We have previously reported that mice lacking the G protein-coupled receptor regulatory protein, β-arrestin 2, display profoundly altered morphine responses. β-Arrestin 2 knockout mice have enhanced and prolonged morphine analgesia with very little morphine tolerance. In this report, we examine whether the side effects of morphine treatment are also augmented in this animal model. Surprisingly, the genetic disruption of opioid receptor regulation, while enhancing and prolonging analgesia, dramatically attenuates the respiratory suppression and acute constipation caused by morphine.Keywords
This publication has 36 references indexed in Scilit:
- Transduction of Receptor Signals by ß-ArrestinsScience, 2005
- Spinophilin Blocks Arrestin Actions in Vitro and in Vivo at G Protein-Coupled ReceptorsScience, 2004
- G protein-coupled receptor kinase 5 regulates airway responses induced by muscarinic receptor activationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Anesthetic Potency and Influence of Morphine and Sevoflurane on Respiration in μ-Opioid Receptor Knockout MiceAnesthesiology, 2001
- Clinical Pharmacology and Adverse EffectsPublished by Cambridge University Press (CUP) ,1998
- Respiratory effects of pressor and depressor agents in conscious ratsCanadian Journal of Physiology and Pharmacology, 1998
- Comparison of naloxonazine and β-funaltrexamine antagonism of μ1 and μ2 opioid actionsLife Sciences, 1991
- Differential development of acute tolerance to analgesia, respiratory depression, gastrointestinal transit and hormone release in a morphine infusion modelLife Sciences, 1989
- Colonic bead expulsion time in normal and μ-opioid receptor deficient (CXBK) mice following central (ICV) administration of μ- and δ-opioid agonistsLife Sciences, 1987
- Relative involvement of receptors subtypes in opioid-induced inhibition of intestinal motility in miceLife Sciences, 1982